PARLIAMENTARY WRITTEN QUESTION
Blood Cancer: Medical Treatments (25 October 2018)
Question Asked
Asked by:
Mark Tami (Labour)
Answer
Clinicians are uniquely placed to explain to individual patients what treatments might or might not benefit them, with reference to their circumstances. NHS England is working with providers, patient groups and manufacturers to ensure appropriate information is made available to help clinicians and patients make informed treatment decisions as Chimeric Antigen Receptor T Cell (CAR-T) therapy starts to be made available through the National Health Service.
Answered by:
Steve Brine (Conservative)
2 November 2018
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.